Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of 18 F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag.
Maoqing JiangPing ChenXiuyu GuoXiaohui ZhangQiaoling GaoJingfeng ZhangGuofang ZhaoJianjun ZhengPublished in: EJNMMI research (2023)
, were associated with EGFR mutations, and that the combination of these factors resulted in a higher differentiation of EGFR mutation status in male patients with NSCLC.